Clarus Lifesciences II, L.P., 10% Owner at Ophthotech Corp. (OPHT), sold 211,680 shares at $44.32 ($9.6M) on 2014-06-11, disclosed to the SEC on 2014-06-11.
Open-market sale of $9.6M OPHT by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.02 | 25,697 | $1.2M | 12.3% |
| 2 | $46.78 | 39,362 | $1.8M | 19.2% |
| 3 | $44.66 | 79,824 | $3.6M | 37.1% |
| 4 | $45.90 | 36,880 | $1.7M | 17.6% |
| 5 | $46.80 | 200 | $9K | 0.1% |
| 6 | $44.32 | 500 |
| $22K |
| 0.2% |
| 7 | $44.53 | 29,217 | $1.3M | 13.5% |
| Total | $45.42 avg | 211,680 | $9.6M | 100% |
| Filing → |
| ACHN | SELL | 2009-12-18 | $731K | — | Filing → |